Furthermore, when we tested each shRNA cell line and its control counterpart by inoculating immunocompromised nu/nu mice with equivalent numbers of cells, we found that in all three cases, endogenous GpIbα knockdown resulted in a significant impairment of tumor growth (Figure 6C). The gene discussed is GP1BA; the disease is neoplasm.